Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma

Oncogene

Volumn 24, Issue 26, 2005, Pages 4232-4242

  Snijders, Antoine M ^a   Schmidt, Brian L ^b   Fridlyand, Jane ^b   Dekker, Nusi ^a   Pinkel, Daniel ^b   Jordan, Richard C K ^a,b   Albertson, Donna G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amplicon; Array CGH; Hedgehog; Notch; Oral SCC

Indexed keywords

INTEGRIN; JAGGED1; MATRILYSIN; NOTCH RECEPTOR; NOTCH4 RECEPTOR; SONIC HEDGEHOG PROTEIN; TALIN;

ADULT; AGED; AMPLICON; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL FATE; CELL MIGRATION; CELL SURVIVAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; CELL TRANSFORMATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MOUTH TUMOR;

ERINACEIDAE;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 20544465379     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208601     Document Type: Article

References (48)

1. Agren M, Kogerman P, Kleman MI, Wessling M and Toftgard R. (2004). Gene, 330, 101-114.
2. Aho S. (2004). J. Cell. Biochem., 92, 1271-1281.
3. Albertson DG, Collins C, McCormick F and Gray JW. (2003). Nat. Genet., 34, 369-376.
4. Ascano JM, Beverly LJ and Capobianco AJ. (2003). J. Biol. Chem., 278, 8771-8779.
5. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN and Beachy PA. (2003). Nature, 425, 846-851.
6. Buckles GR, Rauskolb C, Villano JL and Katz FN. (2001). Development, 128, 3533-3542.
7. Chuang PT, Kawcak T and McMahon AP. (2003). Genes. Dev., 17, 342-347.
8. Chuang PT and McMahon AP. (1999). Nature, 397, 617-621.
9. Fridlyand J, Snijders AM, Pinkel D, Albertson DG and Jain AN. (2004). J. Mulitvariate Anal., 90, 132-153.
10. Garnis C, Coe BP, Zhang L, Rosin MP and Lam WL. (2004). Oncogene, 23, 2582-2586.
11. Ha PK, Benoit NE, Yochem R, Sciubba J, Zahurak M, Sidransky D, Pevsner J, Westra WH and Califano J. (2003). Clin. Cancer Res., 9, 3058-3064.
12. Hansson EM, Lendahl U and Chapman G. (2004). Semin. Cancer Biol., 14, 320-328.
13. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R and Schantz SP. (2002). Genes Chromosomes Cancer, 34, 224-233.
14. Hume WJ and Potten CS. (1979). J. Oral. Pathol., 8, 3-22.
15. Ingham PW and McMahon AP. (2001). Genes Dev., 15, 3059-3087.
16. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG and Pinkel D. (2002). Genome. Res., 12, 325-332.
17. Kim MM and Califano JA. (2004). Int. J. Cancer, 112, 545-553.
18. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS. (2000). Oncogene, 19, 3220-3224.
19. Lefort K and Dotto GP. (2004). Semin. Cancer Biol., 14, 374-386.
20. Lohi J. (2001). Int. J. Cancer, 94, 763-767.
21. Macabeo-Ong M, Shiboski CH, Silverman S, Ginzinger DG, Dekker N, Wong DT and Jordan RC. (2003). Oral Oncol., 39, 638-647.
22. Mao L, Hong WK and Papadimitrakopoulou VA. (2004). Cancer Cell, 5, 311-316.
23. Miele M, Bonatti S, Menichini P, Ottaggio L and Abbondandolo A. (1989). Mutat. Res., 219, 171-178.
24. Mineta H, Borg A, Dictor M, Wahlberg P and Wennerberg J. (1997). Oral Oncol., 33, 42-46.
25. Moore L, Godfrey T, Eng C, Smith A, Ho R and Waldman FM. (2000). Biotechniques, 28, 986-992.
26. Murnane JP and Sabatier L. (2004). BioEssays, 26, 1164-1174.
27. Nayal A, Webb DJ and Horwitz AF. (2004). Curr. Opin. Cell. Biol., 16, 94-98.
28. Neve RM, Ylstra B, Chang CH, Albertson DG and Benz CC. (2002). Oncogene, 21, 3934-3938.
29. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F. (2003). Nat. Genet., 33, 416-421.
30. Nishimaki H, Kasai K, Kozaki K, Takeo T, Ikeda H, Saga S, Nitta M and Itoh G. (2004). Biochem. Biophys. Res. Commun., 314, 313-320.
31. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N and Ooya K. (2004). Int. J. Oral. Maxillofac. Surg., 33, 584-592.
32. Parkin DM, Pisani P and Ferlay J. (1999). CA Cancer J. Clin., 49, 33-64, 1.
33. Pasca di Magliano M and Hebrok M. (2003). Nat. Rev. Cancer, 3, 903-911.
34. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW and Albertson DG. (1998). Nat. Genet., 20, 207-211.
35. Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D, Abecassis J and du Manoir S. (2002). Cancer Res., 62, 6211-6217.
36. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM and Aberger F. (2002). Oncogene, 21, 5529-5539.
37. Roth JR and Andersson DI. (2004). Res. Microbiol., 155, 342-351.
38. Ruiz i Altaba A, Sanchez P and Dahmane N. (2002). Nat. Rev. Cancer, 2, 361-372.
39. Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T and Kanda T. (2005). Exp. Cell Res., 302, 233-243.
40. Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D and Albertson DG. (2003). Oncogene, 22, 4370-4379.
41. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG. (2001). Nat. Genet., 29, 263-264.
42. Taipale J and Beachy PA. (2001). Nature, 411, 349-354.
43. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA and Baylin SB. (2003). Nature, 422, 313-317.
44. Watkins DN and Peacock CD. (2004). Biochem. Pharmacol., 68, 1055-1060.
45. Weng AP and Aster JC. (2004). Curr. Opin. Genet. Dev., 14, 48-54.
46. Westfall PH and Young SS. (1993). Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment. John Wiley & Sons, Inc.: New York.
47. Wolff E, Girod S, Liehr T, Vorderwulbecke U, Ries J, Steininger H and Gebhart E. (1998). Oral. Oncol., 34, 186-190.
48. Zeidler MP, Perrimon N and Strutt DI. (1999). Curr. Biol., 9, 1363-1372.